Sphingosine 1-phosphate mediates proliferation and survival of mesoangioblasts

Stem Cells

Volumn 25, Issue 7, 2007, Pages 1713-1719

  Donati, Chiara ^a   Cencetti, Francesca ^a   Nincheri, Paola ^a   Bernacchioni, Caterina ^a   Brunelli, Silvia ^b,c   Clementi, Emilio ^d,e   Cossu, Giulio ^b,e   Bruni, Paola ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d SCIENTIFIC INSTITUTE   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Apoptosis; Cell signaling; Cellular proliferation; Mammalian stem cells; Sphingosine 1 phosphate

Indexed keywords

CASPASE 3; CERAMIDE; HISTONE; MEMBRANE RECEPTOR; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; STAUROSPORINE; THYMIDINE;

ADULT; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL FUNCTION; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOLOGY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MESOANGIOBLAST; MITOGENESIS; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL;

ADULT; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; LYSOPHOSPHOLIPIDS; MESODERM; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, LYSOSPHINGOLIPID; RNA, MESSENGER; SPHINGOSINE; STEM CELLS;

MAMMALIA;

EID: 34547148609     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0725     Document Type: Article

References (45)

1. De Angelis L, Berghella L, Coletta M et al. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J Cell Biol 1999;147:869-878.
2. Minasi MG, Riminucci M, De Angelis L et al. The meso-angioblast: A multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 2002;129: 2773-2783.
3. Sampaolesi M, Torrente Y, Innocenzi A et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 2003;30:487-492.
4. Galli D, Innocenzi A, Staszewsky L et al. Mesoangioblasts, vessel-associated multipotent stem cells, repair the infarcted heart by multiple cellular mechanisms: A comparison with bone marrow progenitors, fibroblasts, and endothelial cells. Arterioscler Thromb Vasc Biol 2005; 25:692-697.
5. Cossu G, Sampaolesi M. New therapies for muscular dystrophy: Cautious optimism. Trends Mol Med 2004;10:516-520.
6. Spiegel S, Milstien S. Sphingosine-1-phosphate: An enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003;4:397-407.
7. Hla T. Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev Biol 2004;15:513-520.
8. Ishii I, Fukushima N, Ye X et al. Lysophospholipid receptors: Signaling and biology. Annu Rev Biochem 2004;73:321-354.
9. Kimura T, Watanabe T, Sato K et al. Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. Biochem J 2000;348:71-76.
10. Tamama K, Kon J, Sato K et al. Extracellular mechanism through the Edg family of receptors might be responsible for sphingosine-1-phosphate-induced regulation of DNA synthesis and migration of rat aortic smooth-muscle cells. Biochem J 2001;353:139-146.
11. Jin Y, Knudsen E, Wang L et al. 2003. Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation. Blood 2003;101:4909-4915.
12. Ikeda H, Satoh H, Yanase M et al. Antiproliferative property of sphingosine 1-phosphate in rat hepatocytes involves activation of Rho via Edg-5. Gastroenterology 2003;124:459-469.
13. Donati C, Meacci E, Nuti F et al. Sphingosine 1-phosphate regulates myogenic differentiation: A major role for S1P2 receptor. FASEB J 2005;19:449-451.
14. Van Brocklyn JR, Lee MJ, Menzeleev R et al. Dual actions of sphingosine-1-phosphate: Extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J Cell Biol 1998; 142:229-240.
15. Goetzl EJ, Kong Y, Mei B. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. J Immunol 1999;162:2049-2056.
16. Kwon YG, Min JK, Kim KM et al. Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J Biol Chem 2001;276:10627-10633.
17. Sukocheva O, Wadham C, Holmes A et al. Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: The role of sphingosine kinase-1. J Cell Biol 2006;173:301-310.
18. De Palma C, Meacci E, Perrotta C et al. Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: A novel pathway relevant to the pathophysiology of endothelium. Arterioscler Thromb Vasc Biol 2006;26:99-105.
19. Dellavalle A, Sampaolesi M, Tonlorenzi R et al. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 2007;9:255-267.
20. Galvez BG, Sampaolesi M, Brunelli S et al. Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J Cell Biol 2006;17:231-243.
21. Davis MD, Clemens JJ, Macdonald TL et al. Sphingosine 1-phosphate analogs as receptor antagonists. J Biol Chem 2005;280:9833-9841.
22. Osada M, Yatomi Y, Ohmori T et al. Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. Biochem Biophys Res Commun 2002;299:483-487.
23. Sanna MG, Liao J, Jo E et al. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem 2004;279:13839-13848.
24. Duclos F, Straub V, Moore SA et al. Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J Cell Biol 1998;142:1461-1471.
25. Meacci E, Vasta V, Donati C et al. Receptor-mediated activation of phospholipase D by sphingosine 1-phosphate in skeletal muscle C2C12 cells. A role for protein kinase C. FEBS Lett 1999;457:184-188.
26. Becciolini L, Meacci E, Donati C et al. Sphingosine 1-phosphate inhibits cell migration in C2C12 myoblasts. Biochim Biophys Acta 2006;1761: 43-51.
27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001;25:402-408.
28. Bucciantini M, Rigacci S, Berti A et al. Patterns of cell death triggered in two different cell lines by HypF-N prefibrillar aggregates. FASEB J 2005;19:437-439.
29. Sciorati C, Galvez BG, Brunelli S et al. E. Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy. J Cell Sci 2006;119:5114-5123.
30. Chihab R, Porn-Ares MI, Alvarado-Kristensson M et al. Sphingosine 1-phosphate antagonizes human neutrophil apoptosis via p38 mitogen-activated protein kinase. Cell Mol Life Sci 2003;60:776-785.
31. Radeff-Huang J, Seasholtz TM, Matteo RG et al. G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival. J Cell Biochem 2004;92:949-966.
32. Katsuma S, Hada Y, Ueda T et al. Signalling mechanisms in sphingosine 1-phosphate-promoted mesangial cell proliferation. Genes Cells 2002;7: 1217-1230.
33. Pébay A, Wong RCB, Pitson SM et al. Essential roles of sphingosine-1-phosphate and platelet-derived growth factor in the maintenance of human embryonic stem cells. STEM CELLS 2005;23:1541-1548.
34. Van Brocklyn J, Letterle C, Snyder P et al. Sphingosine-1-phosphate stimulates human glioma cell proliferation through Gi-coupled receptors: Role of ERK MAP kinase and phosphatidylinositol 3-kinase beta. Cancer Lett 2002;181:195-204.
35. Pebay A, Toutant M, Premont J et al. Sphingosine-1-phosphate induces proliferation of astrocytes: Regulation by intracellular signalling cascades. Eur J Neurosci 2001;13:2067-2076.
36. Olivera A, Rosenfeldt HM, Bektas M et al. Sphingosine kinase type 1 induces G12/13-mediated stress fiber formation, yet promotes growth and survival independent of G protein-coupled receptors. J Biol Chem 2003;278:46452-46460.
37. Suomalainen L, Hakala JK, Pentikainen V et al. Sphingosine-1-phosphate in inhibition of male germ cell apoptosis in the human testis. J Clin Endocrinol Metab 2003;88:5572-5579.
38. Boujaoude LC, Bradshaw-Wilder C, Mao C et al. Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: Modulation of cellular activity of sphingosine 1-phosphate. J Biol Chem 2001;276:35258-35264.
39. Im DS. Discovery of new G protein-coupled receptors for lipid mediators. J Lipid Res 2004;45:410-418.
40. Yatomi Y, Igarashi Y, Yang L et al. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem (Tokyo) 1997;121:969-973.
41. Berdyshev EV, Gorshkova IA, Garcia JG et al. Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry. Anal Biochem 2005;339: 129-136.
42. Okajima F. Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: Is this an atherogenic mediator or an anti-atherogenic mediator? Biochim Biophys Acta 2002;1582:132-137.
43. Lien YH, Yong KC, Cho C et al. S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney Int 2006;69:1601-1608.
44. Bischoff A, Czyborra P, Meyer Zu Heringdorf D et al. Sphingosine-1- phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. Br J Pharmacol 2000;130:1878-1883.
45. Gardell SE, Dubin AE, Chun J. Emerging medicinal roles for lysophospholipid signaling. Trends Mol Med 2006;12:65-75.